Exhaled nitric oxide (FE NO ) has been used as a marker of asthmatic inflammation in nonoccupational asthma, but some asthmatics have a normal FE NO . In this study we investigated whether, normal FE NO variants have less reactivity in methacholine challenge and smaller peak expiratory flow (PEF) responses than high FE NO variants in a group of occupational asthmatics.
Conclusions:
Occupational asthma patients present as two different variants based on FE NO . The group with normal FE NO have less reactivity in methacholine challenge, while the PEF changes in relation to work are similar.
INTRODUCTION
Measurement of exhaled breath nitric oxide (FE NO ) has been promoted as a measure of airway inflammation in asthma [1] [2] [3] [4] . It has been shown to be correlated with sputum eosinophilia and non specific reactivity in asthmatics [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] but has the advantages of being less invasive for the patient and less labour intensive for the clinician. However, some symptomatic asthmatics have been reported to have normal levels of FE NO [9;15-17] even when factors such as inhaled corticosteroid therapy and smoking have been accounted for. In the diagnosis of occupational asthma, one of the best first line investigations for occupational asthma is serial peak expiratory flow (PEF) monitoring and is recommended by several guidelines [18;19] . It has been suggested previously that using changes in sputum eosinophil counts between periods of exposure and nonexposure increases the sensitivity and specificity of serial PEF measurement in the diagnosis of occupational asthma [20] . Specific inhalation challenge tests to occupational agents have resulted in a mean increase of exhaled nitric oxide levels [21] [22] [23] [24] . However, some workers with positive challenges have not showed changes. We have previously found a strong positive correlation between exhaled nitric oxide level and sputum eosinophil count in workers with occupational asthma exposed to low molecular weight agents and a relationship between sputum eosinophilia and non specific reactivity [9] .
The study suggested that workers can be separated into two variants, those with eosinophilic airways inflammation and those with non-eosinophilic inflammation and that they would also be separable by FE NO due to the strong relationship between the two indices. The aim of this study was to see whether our retrospective analysis could be confirmed with a prospective group, and whether and whether the magnitude of PEF response to occupational exposure is related to FE NO .
METHODS

Study Population
Consecutive workers referred to the Occupational Lung Disease Clinic, Birmingham, UK between November 2001 and December 2004 were recruited who had performed an exhaled nitric oxide measurement (FE NO ), methacholine challenge test and serial PEF record while still exposed at work. Sixty subjects whose serial PEF measurements showed occupational asthma while exposed to the causative agent and who had a diagnosis of occupational asthma formed the study population. The study was approved by the East Birmingham Local Ethics Committee (reference 929).
Measurements
Workers were requested to record PEF every 2 hours from waking to going to bed on work days and days away from work for a total of 4 weeks. The best of 3 PEF readings were recorded on each occasion, provided that the best 2 readings were within 20 l/min of each other. Records were plotted, linearised [25] (if recorded on a non-linear PEF meter) and analysed by the Oasys computer program [26] . Those with a work effect index score ≥ 2.51, (that was used as a cut-off point for definite occupational effect) [26] were included in this analysis.
Spirometry, FE NO and non-specific bronchial reactivity in methacholine challenge were performed within 24 hours of work exposure after withholding treatment with long acting β-agonists for 24 hours (including combined steroid and long acting β-agonists inhalers), short-acting β-agonists for 6 hours and tiotropium for 36 hours as part of their routine clinic visit.
Spirometry was performed on either a wedge bellows Vitalograph spirometer or on the Jaeger pulmonary function system according to ERS/ATS standards [27] . Non-specific bronchial reactivity to methacholine was measured using the Yan technique [28] . FE NO was measured during exhalation at 50ml/second using the Niox from Aerocrine, which requires values from two readings to be within 10% as recommended by the ATS/ERS [29] and performed before spirometry. The Oasys program [26] was used to calculate diurnal variation on days at and away from work and the area between curves (ABC) based on mean PEF on work days and days away from work (ABC score) plotted by waking time (Figure 1 ) [30] . He has normal methacholine reactivity (>4800mcg) and an FE NO of 6.1ppb. The plot has a 56 L/min/hour difference between the mean curves of PEF on work and rest days. In the bottom panel, the first row of numbers is the time from waking in 2-hourly sections e.g. 00-02; 02-04 etc. The second row shows the number of readings used for the mean PEF curves in each 2-hourly section (left side shows work readings and right side shows rest readings). The third row shows the area between the curves for each 2-hourly section which are then used to calculate the ABC score which is in litres/min/hour. A score of ≥ 15 L/min/hr has a sensitivity of 69% and specificity of 100% for occupational asthma diagnosis [30] .
Workers were split into normal and raised nitric oxide level groups based on an eosinophil cut off of 2.2% which was used in our previous study to separate eosinophilic and non eosinophilic variants [9] . A cut off of 14.7ppb for smokers and 22.1ppb for non smokers (equivalent to < or ≥ 2.2% sputum eosinophilia) was selected from a regression analysis of all our previous combined measurements of sputum eosinophils and FE NO .
These values were then used to separate workers into those with normal FE NO and those with raised FE NO levels.
Characteristics of the workers such as smoking history, atopy (defined as at least one positive skin prick test of >3mm wheal to a common environmental allergen using saline and histamine as negative and positive controls) and inhaled corticosteroid treatment were recorded. Inhaled corticosteroids were classified into groups according to the GINA guidelines [31] for analysis against FE NO.
Statistical analysis
Data was analysed by using FE NO as a continuous variable and also by grouping the workers into two variants based on their FE NO level. Physiological data were not normally distributed, so reactivity to methacholine and nitric oxide levels were log transformed. Subjects who had a PD 20 >4,800 µg (the highest dose used) in methacholine challenge had their percent fall in FEV 1 extrapolated to give a PD 20 value. Differences in physiological parameters between groups were assessed using a Mann Whitney U test or Chi-square test for non-parametric data and either independent t-test or one way ANOVA for parametric data (age, FEV 1 percent predicted, ABC PEF score and log transformed reactivity to methacholine and nitric oxide). Multiple linear regression was used for controlling for variables potentially confounding the relation between FE NO and bronchial hyperresponsiveness. Pearson correlation was used to compare reactivity to methacholine and nitric oxide levels when using both as continuous data. The Yates' continuity correction was used when at least one cell count was <5 when performing the Chi-square statistic. SPSS version 15 was used for all statistics.
RESULTS
Workers had a mean age of 44 years and 83% were males. Mean FE NO levels were similar between atopics and non-atopics (p=0.521), males and females (p=0.183) and those with an FEV 1 percent predicted of <80% or >80% (p=0.547). There were eighteen workers at Step 4 of the GINA treatment pathway, eleven at step 3, eight at step 2 and twenty-three on inhaled short acting beta agonists only. There was no difference in log FE NO between these groups (p=0.591). Current smokers had significantly lower nitric oxide levels (p=0.013) compared to ex or never smokers. Those who showed bronchial hyperresponsiveness in methacholine challenge had a significantly higher FE NO (p=0.006). Table 1 shows statistical comparisons of characteristics and physiological parameters between raised and normal FE NO groups, using the different cut-off points for smokers and ex or never smokers. There was a significant positive correlation between reactivity to methacholine and nitric oxide level when both were analysed as continuous data (Pearson correlation =-0.320; p=0.013). When controlling for smoking, inhaled corticosteroid use and atopy (the main determinants of nitric oxide levels) in multiple linear regression, there was still a significant relationship (R 2 =0.221; p=0.009). Figure 2 shows the relationships split by current smokers and ex/ never smokers. were analysed using multiple linear regression controlling for smoking, inhaled corticosteroid use and atopy. There was not a significant relationship (p=0.781). The ABC score was also compared between those with raised and normal FE NO levels in a group of non-smokers who were not taking inhaled corticosteroids. The ABC score was similar (p=0.912). Diurnal variation in PEF was also similar between the two groups (p=0.653).
Workers were analysed for differences in the raised and normal nitric oxide groups according to causative agents (Table 2 ). There were no differences between those with raised and normal FE NO for high versus low molecular weight agents (P=0.898). This study was designed as a follow on to the original Anees et al study [9] . The original observation was from a retrospective analysis, whereas the current paper is wholly prospective data. We started with the hypothesis generated by our previous study that there were two variants of occupational asthma separated by FE NO values that were raised or within normal ranges while exposed, and hypothesised that the response to occupational exposures might differ. By analysing this prospective group, we have confirmed that the two variants differ in non-specific bronchial reactivity, but have not found differences in either the agents responsible for the occupational asthma nor the responses seen in the workplace measured through serial PEFs. The results indicate that FE NO can be used without the need to measure sputum eosinphilia, the former being a simple and cost effective clinical measurement and the latter a much more time-intensive process. There are centres around the world who believe that increased non-specific bronchial reactivity is essential for the diagnosis of occupational asthma. In our experience, normal non-specific reactivity is found in ~30% of workers currently exposed who have occupational asthma. The results therefore support the inclusion of workers with normal non-specific bronchial reactivity within the family of occupational asthma due to sensitisation. Our PEF response results agree with other studies that have also not shown any correlation between FE NO and the magnitude of lung function (mainly FEV 1 ) in non-occupational asthma [41] [42] [43] .
We think that these two variants of occupational asthma separable by the FE NO level may be related to different types of inflammation in the airways, the raised FE NO being related to eosinophilic inflammation and the normal FE NO perhaps to neutrophilic or other types of inflammation, which has also been proposed by Taylor et al [44] . This hypothesis is supported by our previous finding that raised FE NO was significantly correlated with sputum eosinophilia [9] . Others have also found a linkage between eosinophilia and raised nitric oxide levels [45] [46] [47] . We originally hypothesises that the occupational asthmatics with large changes in PEF related to work exposure were more likely to have a raised FeNO than the group with small changes; this however was not supported by our data. Whether these two variants of occupational asthma according to FE NO level have implications for prognosis or treatment of the disease needs to be addressed in future studies. One of the factors relating to prognosis (FEV1% predicted) showed similar means for those with raised and normal FE NO levels indicating that prognostic factors may only explain a small amount of the differences in the two variants. This outcome was significantly different in the original retrospective cohort, but other prognostic factors (length of symptomatic exposure and time from first exposure to disease onset)
were similar between eosinophilic and non-eosinophilic groups.
A number of studies have shown that inhaled corticosteroid use results in a fall in FE NO levels in patients with asthma [48] [49] [50] [51] [52] [53] [54] [55] . As the group with a raised FE NO were on more inhaled ICS than the normal group, we were unable to find a correlation between ICS use and FE NO . A small number of patients may have been misclassified in the normal FE NO group because of this. Workers taking combination inhalers (steroid and long acting beta agonists) would have withheld therapy for 36 hours prior to the clinic appointment for uncompromised non-specific reactivity measurements which may have led to higher FE NO levels in this group. We also found that atopics and non atopics had similar FE NO levels whereas other groups studying asthmatics have found a difference [56] [57] [58] [59] [60] . This may be due to the fact that our cohort is a group of occupational asthmatics which may be acting differently to general asthmatics.
Validity Issues
All workers in our study had PEF records showing a work-rest pattern compatible with occupational asthma and Oasys score >2.51 (sensitivity of 76% and specificity of 94% for occupational asthma [26] ). Workers were recruited consecutively and were currently exposed to the suspected occupational agent at the time of all investigations. There were 12 workers with normal FE NO levels who had a normal reactivity to methacholine and an FEV 1 percent predicted >80%. Although some may regard these subjects as not having occupational asthma, all of them did fulfil the usual definitions of asthma requiring airflow obstruction which varies over short periods of time (here within 24 hours of occupational exposures) and their mean diurnal variation at work was 15%. All workers also had a clear, relevant symptom history compatible with occupational asthma and many were exposed to well known causative agents. In addition, 3 had positive specific inhalation challenge tests to the relevant occupational allergen.
Using a cut off for FE NO may have it's limitations, however we believe that by choosing a previously validated cut off based on sputum eosinophilia, this problem has been addressed. With a sample size increase, we may have seen more difference between groups, although looking at the data we feel this is unlikely.
CONCLUSIONS
We have identified two variants of occupational asthma which cannot be separated according to the degree of asthmatic reaction induced by workplace exposures or the agents that they are exposed to, but can be separated by measurement of exhaled nitric oxide whilst symptomatic. The group with raised FE NO levels have greater reactivity to methacholine compared to those with normal FE NO . This could reflect different types of airway inflammation in these two groups. Whether they differ in prognosis remains a question to be addressed in future studies.
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